CXCL14 as a potential marker for immunotherapy response prediction in renal cell carcinoma.

Qiwen PanRuiqi LiuXinyue ZhangLingling CaiYilin LiPei DongJianming GaoYang LiuLiru He

Published in: Therapeutic advances in medical oncology (2023)

CXCL14 expression is associated with immunotherapy response in RCC. It is a promising biomarker for immunotherapy response prediction and may be an effective epigenetic modulator in combination with immunotherapy approaches.

Keyphrases

renal cell carcinoma
gene expression
poor prognosis
risk assessment
climate change
human health